The Valley Desk

NCT02961491 · Expanded access

Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma

Overall registry status Approved for marketing

Conditions Paraganglioma, Pheochromocytoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov